Shustik C - Search Results

1

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.

Dimopoulos MA, Tedeschi A, Trotman J, García-Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C; iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia. Dimopoulos MA, et al. Among authors: shustik c. N Engl J Med. 2018 Jun 21;378(25):2399-2410. doi: 10.1056/NEJMoa1802917. Epub 2018 Jun 1. N Engl J Med. 2018. PMID: 29856685 Free article. Clinical Trial.

2

[No title available]

[No authors listed] [No authors listed] PMID: 36815271

3

Parathyroid-hormone-related peptide in hematologic malignancies.

Kremer R, Shustik C, Tabak T, Papavasiliou V, Goltzman D. Kremer R, et al. Among authors: shustik c. Am J Med. 1996 Apr;100(4):406-11. doi: 10.1016/S0002-9343(97)89515-0. Am J Med. 1996. PMID: 8610726

4

Iron absorption and therapy after gastric bypass.

Rhode BM, Shustik C, Christou NV, MacLean LD. Rhode BM, et al. Among authors: shustik c. Obes Surg. 1999 Feb;9(1):17-21. doi: 10.1381/096089299765553656. Obes Surg. 1999. PMID: 10065575 Clinical Trial.

5

Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL).

Shustik C, Groulx N, Gros P. Shustik C, et al. Br J Haematol. 1991 Sep;79(1):50-6. doi: 10.1111/j.1365-2141.1991.tb08006.x. Br J Haematol. 1991. PMID: 1911388

6

Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?

Roberge D, Muanza T, Blake G, Shustik C, Vuong T, Freeman CR. Roberge D, et al. Among authors: shustik c. Br J Dermatol. 2007 Jan;156(1):57-61. doi: 10.1111/j.1365-2133.2006.07559.x. Br J Dermatol. 2007. PMID: 17199567

7

Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).

Glass J, Shustik C, Hochberg FH, Cher L, Gruber ML. Glass J, et al. Among authors: shustik c. J Neurooncol. 1996 Dec;30(3):257-65. doi: 10.1007/BF00177277. J Neurooncol. 1996. PMID: 8943101 Clinical Trial.

8

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia.

Shustik C, Bence-Bruckler I, Delage R, Owen CJ, Toze CL, Coutre S. Shustik C, et al. Ann Hematol. 2017 Jul;96(7):1185-1196. doi: 10.1007/s00277-017-2982-1. Epub 2017 Apr 7. Ann Hematol. 2017. PMID: 28389687 Free PMC article. Review.

9

Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism.

Henderson JE, Shustik C, Kremer R, Rabbani SA, Hendy GN, Goltzman D. Henderson JE, et al. Among authors: shustik c. J Bone Miner Res. 1990 Feb;5(2):105-13. doi: 10.1002/jbmr.5650050203. J Bone Miner Res. 1990. PMID: 2316398 Free article.

10

Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma.

Robert F, Roman W, Bramoullé A, Fellmann C, Roulston A, Shustik C, Porco JA Jr, Shore GC, Sebag M, Pelletier J. Robert F, et al. Among authors: shustik c. Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13421-6. doi: 10.1073/pnas.1402650111. Epub 2014 Sep 2. Proc Natl Acad Sci U S A. 2014. PMID: 25197055 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page